InnerCap Technologies, Inc. v. Natals, Inc.

I'll research this case and the parties thoroughly before drafting.

Good initial hits. Let me dig into the docket, the related cases, and the IPR/parallel proceedings.

Case Overview — InnerCap Technologies, Inc. v. Natals, Inc., No. 1:26-cv-00823 (D. Del.)

The parties. InnerCap Technologies, Inc. is a Tampa, Florida life-sciences company founded in 2003 that developed and commercialized a multi-phase, multi-compartment ("capsule-in-capsule") oral delivery platform it markets as NOVACAP (CB Insights company profile; Drug Delivery Technology, Mar. 2010). It is best characterized as a small operating company / patent-holding licensor rather than a classic mass-filing NPE—the portfolio (three filings, anchored to inventor Fred H. Miller) traces to real manufacturing and formulation work, but InnerCap is now asserting its capsule IP against a wave of consumer-supplement sellers. The defendant is Natals, Inc., d/b/a Ritual (PACER Monitor, C.D. Cal. 2:26-cv-05696), the Delaware-registered entity behind Ritual, the direct-to-consumer vitamin/supplement brand best known for "traceable," capsule-in-capsule multivitamin and prenatal products. Notably, Ritual's capsule construction is supplied by third parties and has already generated separate trade-secret litigation: Lonza Sales AG v. Ritual in S.D.N.Y. (1:25-cv-06319), which describes an outer oil/omega fill and a distinct "inner capsule" of solid ingredients (see, e.g., S.D.N.Y. Dkt. 106, 116).

The patent(s) and accused technology. As docketed, this action asserts U.S. Patent No. 9,539,216, "Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same" — granted Jan. 10, 2017; filed Jan. 25, 2016; priority back to Apr. 10, 2002; sole inventor Fred H. Miller; assignee InnerCap Technologies (PubChem patent record). In one line: it claims an oral multi-compartment "capsule-in-capsule" in which a first chamber holds an ingredient in one physical state (e.g., an oil/liquid) and a second chamber holds a different ingredient in a different physical state (e.g., a solid/powder)—typically a vitamin, nutraceutical, dietary supplement, or mineral—with the second chamber enveloped by the first and staggered release, plus methods of filling and sealing such capsules (US 9,539,216 abstract, uspto.report). The '216 is a continuation in the same Miller/InnerCap family as U.S. Pat. No. 7,670,612 (granted Mar. 2, 2010), which InnerCap is asserting in its companion D. Del. suits — InnerCap v. Walmart Inc., No. 1:26-cv-00488 (D. Del. Apr. 27, 2026), and InnerCap v. Nouri Life, Inc., No. 1:26-cv-00903 (D. Del. July 24, 2026) — and in a Minnesota action against Target (No. 0:26-cv-02427 (D. Minn.)). The accused instrumentalities across the campaign are capsule-in-capsule nutraceutical products: in the Nouri Life complaint, an omega-oil outer capsule surrounding a solid inner probiotic (e.g., Lactobacillus plantarum) marketed for delayed gut release (complaint analysis, 1:26-cv-00903). The specific Ritual SKUs accused here are not confirmed by the sources I located, but the pattern—Ritual's oil-plus-inner-capsule multivitamin/prenatal lines—makes them the likely targets; treat the precise product list as an inference pending the Del. complaint.

Procedural posture, venue, and why it matters. Filed July 8, 2026 in the [U.S. District Court for the District of Delaware (Wilmington)](/courts/district-of-delaware-wilmington), nature of suit 830 (patent), assigned to Judge Jennifer L. Hall — the same judge presiding over the Walmart and Nouri Life cases (see the Walmart stay order, referencing "26-00823 JLH" and "26-00903 JLH," entered Aug. 24, 2026) (PACER Monitor, 1:26-cv-00488). Natals is represented in Delaware by Brian E. Farnan and Michael J. Farnan of Farnan LLP (PACER Monitor, 1:26-cv-00823); one aggregator still lists the judge as "pending assignment," so confirm the assignment on the live docket (Ex Parte/PACER synopsis). The case is strategically central because Judge Hall stayed the Walmart action pending completion of this case and Nouri Life — i.e., the court is treating the brand/manufacturer suits as lead or bellwether cases on infringement and validity, with retailer-defendant cases held in abeyance. Two features make it notable: (1) a race-to-the-courthouse dynamic — Ritual filed a declaratory-judgment action against InnerCap in C.D. Cal. on May 27, 2026 (No. 2:26-cv-05696, before Judge Michael W. Fitzgerald), then voluntarily dismissed it without prejudice on Aug. 27, 2026, after InnerCap sued it in Delaware, leaving Delaware as the forum (PACER Monitor docket); and (2) industry impact — capsule-in-capsule is now a mainstream format in premium DTC supplements and probiotics, so a broad enforcement of a 2002-priority family against brand owners and retailers could pressure the entire category, while the early priority date and long prosecution history leave the asserted claims exposed to validity attack. Sourcing caveats: I found no public record of any IPR, PGR, or other PTAB challenge to the '216 or '612 patents, and no opinion or substantive ruling in the Natals action; the case remains at an early pleading stage. Party descriptions, docket dates, and counsel are drawn from PACER/docket aggregators and patent records as cited above, while the exact accused Ritual products and any damages theory should be verified against the complaint itself, which I could not retrieve in full.

I'll research this case systematically. Let me start with the core case identifiers and the patent at issue.

Let me gather docket details, related cases, and any PTAB proceedings.

Research note on sourcing

This case is only about three months old as of today (filed 2026‑07‑08), so the record is thin. I was able to confirm the core proceedings, the parties, the patent, related actions, and the parallel California suit, but I could not verify any answer, counterclaims, motion practice, Markman proceeding, discovery orders, trial events, or PTAB filing in the Natals action itself. Where I cannot confirm something, I say so explicitly rather than infer it.

---

Case snapshot

The patent. U.S. 9,539,216, "Multi‑phase, multi‑compartment, capsular delivery apparatus and methods for using same," inventor Fred H. Miller, assigned to InnerCap Technologies, Inc. (PubChem US‑9539216‑B2; Google Patents). It claims a multi‑compartment ("capsule‑in‑capsule") delivery vehicle separating ingredients of different physical states, with the ingredient classes recited as "nutraceutical, vitamin, dietary supplement and mineral." Earliest priority is 2002‑04‑10; the application was filed 2016‑01‑25 and the patent issued 2017‑01‑10. Google Patents currently lists its legal status as "Expired ‑ Lifetime," which — if accurate — is a potentially dispositive strategic fact worth verifying against USPTO maintenance‑fee records (I could not confirm the fee/expiration history via the sources retrieved; treat the "expired" label as unverified).

The '216 sits in a family InnerCap has asserted before, including U.S. 7,670,612, 8,361,497, 9,241,911, and 9,539,216 (see the analysis of InnerCap's sister complaint, below).

---

Chronological legal developments

1. Anticipatory filing by Natals in California — 2026‑05‑27 (before the Delaware suit)

Natals, Inc. (d/b/a Ritual, the vitamin/supplement brand) filed first, on 2026‑05‑27, in the Central District of California: Natals, Inc. v. InnerCap Technologies, Inc., No. 2:26‑cv‑05696, assigned to Judge Michael W. Fitzgerald with Magistrate Judge A. Joel Richlin. Nature of suit 830 (patent). Natals' counsel of record is Melissa N. Eubanks (VGC LLP). Natals filed a "Notice of Pendency of Other Actions" (D.I. 5) contemporaneously with the complaint, which is consistent with — though not conclusive of — a declaratory‑judgment/race‑to‑the‑courthouse posture. (PACER Monitor docket)

Dismissed without prejudice on 2026‑08‑27 (D.I. 14, Notice of Voluntary Dismissal under FRCP 41(a)(1)), roughly seven weeks after InnerCap filed the Delaware action — the classic pattern when a first‑filed DJ action is abandoned after the patentee sues on its home/forum‑of‑choice turf. Whether the dismissal was part of a forum agreement with InnerCap is not shown in the records retrieved.

2. InnerCap files the Delaware action — 2026‑07‑08

InnerCap filed the instant complaint in D. Del. on 2026‑07‑08, NOS 830, cause 35:271, naming Natals, Inc. (PACER Monitor; Ex Parte case page). Delaware local counsel is Farnan LLP. The docket was last checked 2026‑07‑08, so the answer/counterclaim pleadings, if any, are not reflected in the retrieved records.

Accused products. The record I could retrieve describes Natals d/b/a Ritual as a vitamin/supplement maker; given the patent's "vitamin/nutraceutical" claim scope, InnerCap's theory is presumably that Ritual's capsule products (e.g., its multi‑nutrient capsule lines) use a capsule‑in‑capsule or multi‑compartment format. I could not verify the specific accused product(s) in the Natals complaint — this should be confirmed from the complaint itself.

3. Sister case: InnerCap v. Nouri Life — filed 2026‑07‑24

Sixteen days later, InnerCap filed InnerCap Technologies, Inc. v. Nouri Life, Inc., No. 1:26‑cv‑00903‑JLH (D. Del.), before the same judge (case page). Per a complaint analysis of that docket, InnerCap asserted U.S. 7,670,612 (independent claim 33, reserving claims 5, 6, 9, 10, 24, 65) against Nouri's capsule‑in‑capsule probiotic products (Hormone Balance Probiotic, Digestive Support Probiotic, with the Digestive Support Probiotic as representative). The asserted claim 33 covers a multi‑compartment hard‑shell capsule with an oil‑containing immediate‑release outer chamber enveloping a solid, time‑delayed inner chamber (Ex Parte complaint analysis). Note: that analysis is a third‑party/AI‑generated summary, not a court document — treat its claim‑limitation detail as indicative, not authoritative.

The Nouri case confirms InnerCap is running a coordinated multi‑defendant campaign against supplement makers, with the Natals and Nouri suits proceeding together before Judge Hall.

4. Walmart action stayed pending Natals and Nouri — 2026‑08‑24

The earliest InnerCap complaint, InnerCap Technologies, Inc. v. Walmart Inc., No. 1:26‑cv‑00488‑JLH (D. Del., also before Judge Hall), was stayed by stipulation on 2026‑08‑24, "pending completion of InnerCap Technologies, Inc. v. Natals, Inc., 26‑00823 JLH and InnerCap Technologies, Inc. v. Nouri Life, Inc., 26‑00903 JLH." The order granted D.I. 18 and was signed by Judge Hall (PACER Monitor). This makes the Natals case — as the case metadata notes — the lead case for the campaign: the Walmart action is held in abeyance while Natals and Nouri serve as the vehicle for resolving the core liability questions.

5. Pre‑trial motions of substance

• Motions to dismiss / transfer: none identified. The California action was resolved by voluntary dismissal, not by a §1404/§1406 or §1407 ruling that I could find.
• Stay pending IPR: none identified. See the PTAB section — no IPR was found on the '216.
• The only stay of substance is the stipulated stay in the Walmart case (2026‑08‑24), which is inter‑case sequencing rather than an IPR stay.

6. Claim construction (Markman)

Not reached. The Natals case was roughly five months old at the time of the records retrieved and no scheduling order, joint claim construction statement, Markman hearing, or claim construction opinion appears in the accessible docket. Same for the Nouri sister case.

7. Discovery milestones

None identified. No scheduling order, discovery dispute, protective‑order, ESI, or expert deadlines were retrievable. Given the ~2026‑07 timeframe, the case is likely still in Rule 26(f)/initial‑disclosure posture, but I cannot confirm that from the sources available.

8. Trial, verdict, post‑trial motions

None. No trial date, no verdict, no JMOL/new‑trial/fee motions.

9. Disposition / present posture

Active and early. The Natals action remains open and is the designated lead case; the Walmart action is stayed behind it; the parallel California action Natals filed against InnerCap was voluntarily dismissed without prejudice on 2026‑08‑27.

10. Parallel PTAB proceedings

None found. Searches of PTAB/IPR materials for U.S. 9,539,216 (and for InnerCap's asserted patents generally) returned no IPR, PGR, or CBM proceeding. I did not find a petitioner filing by Natals/Ritual or by Walmart. That absence is notable: in a campaign of this type, a defendant‑side IPR on the '216 (or on the '612 asserted against Nouri) would be the expected next move, and it would likely trigger a stay motion in the lead case. If no IPR has been filed by now (2026‑10‑12), the 35 U.S.C. § 315(b) one‑year bar from service would run in mid‑2027, so any IPR petition would be expected in the coming months. I could not confirm whether one has been filed — this should be re‑checked against the PTAB Patent Trial and Appeal Board End‑to‑End (PTAB E2E) system.

---

Strategic observations

1. Forum fight resolved in InnerCap's favor. Natals sued first (C.D. Cal., 2026‑05‑27), but InnerCap's Delaware complaint (2026‑07‑08) effectively displaced it, and Natals dismissed the California case on 2026‑08‑27.
2. The case is the tip of a coordinated campaign. Three D. Del. actions before Judge Hall (Walmart, Natals, Nouri), all by Farnan LLP for InnerCap; the two smaller defendants are being litigated first while Walmart waits.
3. The '216 patent's validity/value is the central open question. Its 2002 priority and Google's "Expired ‑ Lifetime" status flag a real possibility that the patent has lapsed or that its term is near/at its end — a fact that would undercut the entire injunction/damages posture. This is the single most important item to verify (USPTO maintenance‑fee records / Patent Center).
4. Watch for an IPR petition. With

I'll research this case's docket and counsel. Let me run several searches.

Good initial hits. Let me dig into the docket and firm details.

Let me research the Farnan firm and the out-of-state counsel appearing in the related InnerCap cases.

Counsel of Record — Plaintiff InnerCap Technologies, Inc.

Case: InnerCap Technologies, Inc. v. Natals, Inc., No. 1:26-cv-00823-JLH (D. Del., filed July 8, 2026) (Judge Jennifer L. Hall)
Patent-in-suit: U.S. Pat. No. 9,539,216 (related InnerCap complaints assert the capsule-in-capsule family, incl. U.S. Pat. No. 7,670,612)

---

A. Confirmed on the docket (Delaware counsel)

The PACER Monitor docket page for 1:26-cv-00823 lists a single represented party — the plaintiff, InnerCap Technologies, Inc. — with two attorneys of record, both at Farnan LLP (Wilmington, Delaware):

Source: PACER Monitor case page for 1:26-cv-00823 ("Represented By — Brian E. Farnan, Farnan LLP; Michael J. Farnan"), https://www.pacermonitor.com/public/case/65590158/InnerCap_Technologies,_Inc_v_Natals,_Inc. Note that page's docket was last checked 7/8/2026 (the filing date), so it reflects only the initial appearance — see caveats below.

No in-house counsel and no additional out-of-state counsel are confirmed on the 823 docket as of that snapshot.

---

B. Likely outside/lead trial counsel (strong inference, not yet confirmed in 823)

InnerCap has used a single outside team across its parallel campaign. In the three companion cases — InnerCap v. Walmart, No. 1:26-cv-00488-JLH (D. Del.); InnerCap v. Nouri Life, Inc., No. 1:26-cv-00903-JLH (D. Del.); and InnerCap v. Target Corp., No. 0:26-cv-02427 (D. Minn.) — the following attorneys were admitted pro hac vice for InnerCap and are listed as Folio Law Group PLLC (Seattle, WA):

Sources: PACER Monitor docket summaries for 1:26-cv-00488 and 1:26-cv-00903; D. Del. docket entries 7–8 and 11–12 in 1:26-cv-00488; PACER Monitor page for 0:26-cv-02427 (Target) listing "Cristofer Leffler — Folio Law Group PLLC."

Important caveat: I did not find a pro hac vice motion or appearance by any Folio Law Group attorney on the 1:26-cv-00823 docket itself. The Farrell/Farnan representation is the only entry confirmed by the sources retrieved. The Folio team is included because (a) they are the same client's counsel in four closely related InnerCap matters, and (b) 823 is expressly the lead case referenced in the Walmart stay order ("SO ORDERED, re 18 Stipulation and Order to Stay pending completion of InnerCap Technologies, Inc. v. Natals, Inc., 26-00823 JLH and InnerCap Technologies, Inc. v. Nouri Life, Inc., 26-00903 JLH"). Treat row B as anticipated, unverified for 823 until a PHV motion appears.

---

C. What is not established

• No lead-counsel designation is visible: the 823 docket snapshot shows no "lead attorney" flag; D. Del. practice does not formally designate lead trial counsel on the docket, and no Rule 26/§ 4.1 disclosure or scheduling order was retrievable.
• No in-house InnerCap attorney (e.g., from InnerCap's Tampa, FL headquarters) appears in any retrieved docket entry.
• Sealing: nothing retrieved indicates the 823 docket is under seal; the absence of out-of-state counsel entries is more likely explained by the snapshot's timing (last checked on the filing date) than by sealing.
• Defendant side (context only): in the parallel DJ action Natals, Inc. d/b/a Ritual v. InnerCap Techs., Inc., No. 2:26-cv-05696 (C.D. Cal., filed 2026), Natals is represented by Melissa N. Eubanks of VGC, LLP — not plaintiff-side counsel here, but relevant to the coordinated litigation picture.

D. Where to verify (recommended next steps)

1. Direct PACER pull of the 1:26-cv-00823 docket sheet (Entered dates after 7/8/2026) for any motions for pro hac vice under D. Del. L.R. 83.5(d).
2. Fiscal Courtlink/Docket Alarm entries for the 823 case (use the "Last checked" timestamp — the PACER Monitor capture is stale).
3. Confirm the Folio Law Group attorney roster and office on the firm's own site and the Law360 firm page for Folio Law Group, plus the InnerCap PHV motions (which list each attorney's bar admissions and address of record).

Confidence: High on Brian E. Farnan and Michael J. Farnan (Farnan LLP) as Delaware counsel of record. Moderate on the Folio Law Group team being lead/outside counsel in 823 specifically — it is documented in four companion InnerCap cases but not yet in this one.

I'll research the defendant-side counsel. Note there's a potential internal contradiction between the previously generated sections (Case Overview says Farnan LLP represents Natals; the Plaintiff Representatives section says Farnan LLP represents InnerCap), so I'll try to resolve that too.

The PACER Monitor snippet doesn't say which party Farnan represents. Let me resolve that and find defendant-side counsel.

Let me pull the actual docket and resolve which party Farnan represents, plus find Natals' counsel.